Granules India is reportedly planning to invest $35 million to expand operations of its wholly owned subsidiary Granules Pharmaceuticals Inc in the US. The pharmaceutical research & development and manufacturing capacities of the subsidiary will get a boost with the funding.
Currently, it is a 100,000-sq foot facility in the Chantilly area of Fairfax County, Virginia. The company conducts research and development to formulate products, and intends to manufacture products in the location as well.
Granules India, the Hyderabad-head quartered company, manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates and finished dosages. It intends to increase its global presence with a firm base and operations in the US.
